Ionis Pharmaceuticals Inc (IONS)
42.96
-0.05
(-0.12%)
USD |
NASDAQ |
May 02, 10:21
Ionis Pharmaceuticals Free Cash Flow (Quarterly): 32.89M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.89M |
| September 30, 2023 | -112.26M |
| June 30, 2023 | -110.44M |
| March 31, 2023 | -145.72M |
| December 31, 2022 | -205.20M |
| September 30, 2022 | -31.49M |
| June 30, 2022 | -22.60M |
| March 31, 2022 | -35.18M |
| December 31, 2021 | 199.70M |
| September 30, 2021 | -60.17M |
| June 30, 2021 | -68.96M |
| March 31, 2021 | -57.66M |
| December 31, 2020 | 91.10M |
| September 30, 2020 | -23.25M |
| June 30, 2020 | -55.44M |
| March 31, 2020 | -17.58M |
| December 31, 2019 | 268.90M |
| September 30, 2019 | -30.59M |
| June 30, 2019 | -32.40M |
| March 31, 2019 | 103.44M |
| December 31, 2018 | 113.39M |
| September 30, 2018 | -30.71M |
| June 30, 2018 | 492.49M |
| March 31, 2018 | 10.08M |
| December 31, 2017 | 13.34M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.975M |
| June 30, 2017 | -4.463M |
| March 31, 2017 | 118.44M |
| December 31, 2016 | -30.68M |
| September 30, 2016 | 22.06M |
| June 30, 2016 | -38.23M |
| March 31, 2016 | -76.78M |
| December 31, 2015 | -40.61M |
| September 30, 2015 | 33.29M |
| June 30, 2015 | 61.12M |
| March 31, 2015 | -44.42M |
| December 31, 2014 | 65.99M |
| September 30, 2014 | 0.423M |
| June 30, 2014 | -37.17M |
| March 31, 2014 | -34.06M |
| December 31, 2013 | -16.02M |
| September 30, 2013 | 63.75M |
| June 30, 2013 | 21.90M |
| March 31, 2013 | -11.50M |
| December 31, 2012 | 34.68M |
| September 30, 2012 | -26.23M |
| June 30, 2012 | -4.571M |
| March 31, 2012 | -7.173M |
| December 31, 2011 | -25.13M |
| September 30, 2011 | -26.91M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-205.20M
Minimum
Dec 2022
268.90M
Maximum
Dec 2019
-21.91M
Average
-32.40M
Median
Jun 2019
Free Cash Flow (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -80.97M |
| Viking Therapeutics Inc | -6.134M |
| Alnylam Pharmaceuticals Inc | -45.10M |
| Akero Therapeutics Inc | -48.63M |
| 89bio Inc | -34.29M |